EyePoint Pharmaceuticals files $200 million common stock offering prospectus By Investing. - Stock Watch Index

EyePoint Pharmaceuticals files $200 million common stock offering prospectus By Investing.

November 6, 2025

EyePoint Pharmaceuticals files $200 million common stock offering prospectus

Search

RECENT PRESS RELEASES

Earnings call transcript: Screen Holdings Q2 2025 sees robust growth By Investing.com

SWI Editorial Staff2025-11-07T04:14:44-08:00November 7, 2025|

70% of New ETF Investors Say They’d Go All In — Even Though Most Only Started in 2020

SWI Editorial Staff2025-11-07T04:14:19-08:00November 7, 2025|

How to invest in the artificial intelligence boom

SWI Editorial Staff2025-11-07T04:13:53-08:00November 7, 2025|

JPMorgan downgrades Lojas Renner stock to Neutral on execution challenges By Investing.com

SWI Editorial Staff2025-11-07T04:13:31-08:00November 7, 2025|

Earnings call transcript: Columbus Q3 2025 revenue beats expectations By Investing.com

SWI Editorial Staff2025-11-07T04:13:03-08:00November 7, 2025|

OneMeta Inc. enters $2 million convertible note and warrant agreements By Investing.com

SWI Editorial Staff2025-11-07T04:12:39-08:00November 7, 2025|

Related Post